← Back to Home
Strategic Work Portfolio

Strategy-led work across positioning, GTM, AI use cases, and commercial intelligence.

A curated selection of strategic thinking across GTM planning, market narratives, ICP frameworks, positioning, launch strategy, AI use-case development, and decision intelligence for pharma, life sciences, and B2B growth contexts.

03 Featured strategic documents
AI + Pharma Core portfolio theme
GTM Positioning, ICP, and commercial strategy

Overview

This section highlights strategy-led work samples that show how I structure ambiguous business challenges, translate market signals into actionable narratives, and build practical frameworks that support commercial, marketing, and AI-enabled growth decisions.

Featured Work Samples

Each sample is selected to demonstrate a different layer of strategic work: company repositioning, life-science service design, and account-based prospecting for AI-enabled pharma workflows.

01
Corporate Repositioning

Corporate Repositioning Proposal: Decision Intelligence

A strategic repositioning proposal outlining the shift from a traditional BI/dashboard vendor to a pharma-native Decision Intelligence partner.

The work reframes the company narrative around the idea: “The data exists. The decision doesn't.”

Focus: corporate positioning, market narrative, pharma GTM, competitive differentiation, decision intelligence.
View work sample
02
Capabilities & Service Overview

Lifescience Service Stack

A capabilities and service overview outlining Phamax’s core capabilities and AI-enabled decision intelligence services for Life Sciences and Healthcare teams.

The document presents six operational pillars, including Market & Competitive Intelligence, Advanced Commercial Analytics, and Market Access Intelligence.

Focus: life sciences strategy, service portfolio design, decision intelligence, commercial analytics, market access intelligence.
View work sample
03
ABM / ICP Playbook

Medical Affairs Prospecting Framework

An ICP-led prospecting and marketing playbook for MYAIA within the pharmaceutical sector.

The framework defines a structured scoring model for account prioritization, maps the buying committee across Medical Affairs roles such as MedInfo, MSL, and Drug Safety, and translates these insights into targeted value propositions.

Focus: ICP strategy, account-based marketing, pharma prospecting, buying committee mapping, AI assistant positioning.
View work sample